Projected Income Statement: Newmont Corporation

Forecast Balance Sheet: Newmont Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 1,162 1,228 2,426 6,434 5,308 -1,247 -6,735 -14,011
Change - 5.68% 97.56% 165.21% -17.5% -123.49% -440.1% -108.03%
Announcement Date 18/02/21 24/02/22 23/02/23 22/02/24 20/02/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Newmont Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 1,302 1,653 2,131 2,666 3,402 3,036 3,336 3,283
Change - 26.96% 28.92% 25.11% 27.61% -10.76% 9.87% -1.57%
Free Cash Flow (FCF) 1 3,588 2,626 1,089 97 2,916 6,563 8,222 9,090
Change - -26.81% -58.53% -91.09% 2,906.19% 125.08% 25.27% 10.56%
Announcement Date 18/02/21 24/02/22 23/02/23 22/02/24 20/02/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Newmont Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 48.16% 48.79% 38.19% 35.7% 46.44% 59.42% 65.03% 65.85%
EBIT Margin (%) 24.41% 10.28% 1.7% -13.91% 24.23% 49.44% 53.78% 53.37%
EBT Margin (%) 27.34% 9.07% -0.43% -16.69% 24.5% 50.92% 53.71% 55.2%
Net margin (%) 24.61% 9.54% -3.6% -20.95% 17.92% 36.04% 36.75% 38.67%
FCF margin (%) 31.21% 21.49% 9.14% 0.82% 15.61% 29.79% 32.79% 35.39%
FCF / Net Income (%) 126.83% 225.21% -253.85% -3.92% 87.1% 82.67% 89.21% 91.52%

Profitability

        
ROA 6.96% 5.79% - 2.89% 7.14% 12.98% 15.04% 14.54%
ROE 9.63% 10.53% 7.1% 5.61% 13.54% 22.33% 23.87% 20.64%

Financial Health

        
Leverage (Debt/EBITDA) 0.21x 0.21x 0.53x 1.53x 0.61x - - -
Debt / Free cash flow 0.32x 0.47x 2.23x 66.33x 1.82x - - -

Capital Intensity

        
CAPEX / Current Assets (%) 11.32% 13.52% 17.89% 22.57% 18.21% 13.78% 13.3% 12.78%
CAPEX / EBITDA (%) 23.51% 27.72% 46.84% 63.22% 39.22% 23.19% 20.46% 19.41%
CAPEX / FCF (%) 36.29% 62.95% 195.68% 2,748.45% 116.67% 46.25% 40.57% 36.12%

Items per share

        
Cash flow per share 1 6.067 5.342 6.44 3.885 6.396 8.933 10.35 11.58
Change - -11.95% 20.56% -39.68% 64.65% 39.66% 15.91% 11.81%
Dividend per Share 1 1.45 2.2 2.05 1.6 1 1 1.01 1
Change - 51.72% -6.82% -21.95% -37.5% 0% 1% -0.99%
Book Value Per Share 1 28.75 27.49 24.41 25.19 26.07 31.8 38.48 45.05
Change - -4.37% -11.23% 3.19% 3.51% 21.97% 21.01% 17.08%
EPS 1 3.51 1.46 -0.54 -2.94 2.92 7.202 8.363 8.995
Change - -58.4% -136.99% -444.44% 199.32% 146.64% 16.13% 7.55%
Nbr of stocks (in thousands) 801,309 799,026 793,739 1,152,544 1,129,999 1,088,531 1,088,531 1,088,531
Announcement Date 18/02/21 24/02/22 23/02/23 22/02/24 20/02/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 15.8x 13.6x
PBR 3.59x 2.97x
EV / Sales 5.58x 4.69x
Yield 0.88% 0.88%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
114.15USD
Average target price
112.94USD
Spread / Average Target
-1.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NEM Stock
  4. Financials Newmont Corporation